Danielle Miller

Danielle Miller

Auto-generated profile, based on publicly available information

Danielle Miller

Converge Bio Ltd

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2009 in Biomaterials
Verified
Journal Article
Closed access
ACAdam S. Crouch
Adam S. Crouch
DMD. Miller
D. Miller
KLKevin J. Luebke
Kevin J. Luebke
WHWenchuang (Walter) Hu
Wenchuang (Walter) Hu

29 September 2022 in Nature Communications
Verified
Journal Article
Open access
PDF file
DMDanielle Miller
Danielle Miller
ASAdi Stern
Adi Stern
DBDavid Burstein
David Burstein
Revealing the function of uncharacterized genes is a fundamental challenge in an era of ever-increasing volumes of sequencing data. Here, we present a concept for tackling this challenge using deep learning methodologies adopted from natural language processing (NLP). We repurpose NLP algorithms to model “gene semantics” based on a biological corpus of more than 360 million microbial genes within their genomic context. We use the language models to predict functional categories for 56,617 genes and find that out of 1369 genes associated with recently discovered defense systems, 98% are inferred correctly. We then systematically evaluate the “discovery potential” of different functional categories, pinpointing those with the most genes yet to be characterized. Finally, we demonstrate our method’s ability to discover systems associated with microbial interaction and defense. Our results highlight that combining microbial genomics and language models is a promising avenue for revealing gene functions in microbes.

21 August 2020 in Science Advances
Verified
Journal Article
Open access
PDF file
MMMoran Meir
Moran Meir
NHNoam Harel
Noam Harel
DMDanielle Miller
Danielle Miller
MGMaoz Gelbart
Maoz Gelbart
AEAvigdor Eldar
Avigdor Eldar
ASAdi Stern
Adi Stern
Conflict between mutant viruses is driven by cheater-of-cheater dynamics, leading to the fall of one cheater and rise of another.

30 January 2024 in Bioinformatics
Verified
Journal Article
Open access
PDF file
DMDanielle Miller
Danielle Miller
OAOfir Arias
Ofir Arias
DBDavid Burstein
David Burstein
Summary: GeNLP is a web application that enables exploring microbial gene “semantics” and predictions of uncharacterized gene families based on their genomic context. It utilizes a pre-trained language model to uncover gene relationships and allows users to access and utilize the data as well as make their own predictions through an interactive interface. Availability and implementation: The web application is accessible from all browsers at: http://gnlp.bursteinlab.org/. All source codes are freely available from GitHub under the MIT license here: https://github.com/burstein-lab/genomic-nlp-server.

12 May 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
NSNoam Shahar
Noam Shahar
DMDanielle Miller
Danielle Miller
MSMeishar Shahoha
Meishar Shahoha
GLGuy Lurie
Guy Lurie
IWIddo Weiner
Iddo Weiner
Translating transcriptomic data into therapeutic hypotheses remains fragmented and labor-intensive. Here we present ConvergeCELL, a platform combining a patient representation model trained on over 20 million cells across 4,479 patients, an interpretability framework for gene discovery, and a large language model-driven workflow that classifies candidates along an evidence hierarchy and constructs mechanism-of-action hypotheses. Validated on held-out cohorts spanning lupus, multiple myeloma, and sepsis across single-cell and bulk modalities, ConvergeCELL recovers known disease-associated genes at or above differential expression, machine-learning, and patient-level foundation model (PaSCient) baselines. The advantage is most pronounced for clinically validated, disease-specific drug targets: ConvergeCELL ranks TNFSF13B (Belimumab; lupus), TNFRSF17/BCMA (Belantamab; myeloma), and CXCR4 (Plerixafor; myeloma) within the top 0.3% of its gene rankings - significantly outcompeting alternative approaches. ConvergeCELL delivers an end-to-end translational workflow with state-of-the-art performance on both disease-associated gene recovery and patient-level disease classification. The pretrained ConvergeCELL patient representation model and bulk distillation module are publicly available on Hugging Face (huggingface.co/ConvergeBio/virtual-cell-patient) under the Apache 2.0 license.